Vimarsana
Biggest News Aggregation in the World

Page 4 - Nyse Ebs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nyse Ebs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nyse Ebs Today - Breaking & Trending Today

Brokerages Set Emergent BioSolutions Inc. (NYSE:EBS) Target Price at $28.00 - Vimarsana News

Brokerages Set Emergent BioSolutions Inc. (NYSE:EBS) Target Price at $28.00

Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have been given a consensus recommendation of “Hold” by the seven brokerages that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and two have given a buy recommendation to […]

Emergent BioSolutions Inc. (NYSE:EBS) Given Average Rating of "Hold" by Brokerages - Vimarsana News

Emergent BioSolutions Inc. (NYSE:EBS) Given Average Rating of "Hold" by Brokerages

Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have received a consensus recommendation of “Hold” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and two have given a buy recommendation to the company. […]

Source: wkrb13.com
Prescott Group Capital Management L.L.C. Takes Position in Emergent BioSolutions Inc. (NYSE:EBS) - Vimarsana News

Prescott Group Capital Management L.L.C. Takes Position in Emergent BioSolutions Inc. (NYSE:EBS)

Prescott Group Capital Management L.L.C. purchased a new position in Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 91,000 shares of the biopharmaceutical company’s stock, valued at approximately $1,075,000. Prescott Group Capital Management L.L.C. […]

Emergent BioSolutions (NYSE:EBS) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Emergent BioSolutions (NYSE:EBS) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Emergent BioSolutions (NYSE:EBS – Get Rating) in a report released on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. Benchmark upgraded Emergent BioSolutions from a hold rating to a buy rating and […]

Emergent BioSolutions (NYSE:EBS) Posts Quarterly Earnings Results, Misses Expectations By $1.50 EPS - Vimarsana News

Emergent BioSolutions (NYSE:EBS) Posts Quarterly Earnings Results, Misses Expectations By $1.50 EPS

Emergent BioSolutions (NYSE:EBS – Get Rating) announced its earnings results on Tuesday. The biopharmaceutical company reported ($3.17) EPS for the quarter, missing the consensus estimate of ($1.67) by ($1.50), Briefing.com reports. Emergent BioSolutions had a negative net margin of 19.97% and a negative return on equity of 7.57%. The firm had revenue of $165.10 million […]

Source: wkrb13.com